nDatalyze
is a Public company. nDatalyze 's IPO date was on Aug 2024. James Durward is the President & CEO of nDatalyze . nDatalyze has received a total of $427.8K in funding. nDatalyze 's most recent acquisition was MindBalanced Inc for an undisclosed amount on Mar 2024. nDatalyze has 1 followers on Owler.nDatalyze
is a Public company. nDatalyze 's IPO date was on Aug 2024. James Durward is the President & CEO of nDatalyze . nDatalyze has received a total of $427.8K in funding. nDatalyze 's most recent acquisition was MindBalanced Inc for an undisclosed amount on Mar 2024. nDatalyze has 1 followers on Owler.
News
Nov 03, 2025
TheNewswire
Press Release: nDatalyze : nDatalyze Corp. Updates the RTO Progress
May 15, 2025
TheNewswire
Press Release: nDatalyze : nDatalyze Corp. Announces the Release of Sigmund v.4, the Corporation's Machine-learning/AI-enhanced Mental Assessment.
Mar 19, 2025
TheNewswire
Press Release: nDatalyze : nDatalyze Corp. ("NDAT" or the "Corporation") (CSE:NDAT) (OTCQB:NDATF) provides a progress update to the previously-announced Reverse Takeover ("RTO").
Jan 28, 2025
TheNewswire
Press Release: nDatalyze : nDatalyze Corp. ("NDAT" or the "Corporation") (CSE:NDAT) (OTCQB:NDATF) completes its due-diligence related to the previously-announced Reverse Takeover ("RTO").
Jan 15, 2025
TheNewswire
Press Release: nDatalyze : nDatalyze Corp. ("NDAT" or the "Corporation") (CSE:NDAT) (OTCQB:NDATF) Comments on the Recent Share Price Decline
Dec 27, 2024
TheNewswire
Press Release: nDatalyze : nDatalyze Corp. ("NDAT" or the "Corporation") (CSE:NDAT) (OTCQB:NDATF) Announces a Letter of Intent regarding a Reverse Merger.
Dec 12, 2024
TheNewswire
Press Release: nDatalyze : nDatalyze Corp. Announces its AI-based Depression Assessment Availability Through the Largest Canadian Electronic Medical Record ("EMR ") Platforms.
Oct 24, 2024
Marketscreener
nDatalyze : NDatalyze Corp. Reports Earnings Results for the Second Quarter and Six Months Ended August 31, 2024
Jun 11, 2024
MarketScreener
nDatalyze : NDatalyze : Clinical Study Update #2 - June 11, 2024
Jun 04, 2024
TheNewswire
Press Release: nDatalyze : nDatalyze Corp. ("NDAT" or the "Corporation") (CSE:NDAT) (OTC:NDATF) updates the Clinical Study